Home/Curovir/Johan Claesson

JC

Johan Claesson

Founder and Owner

Therapeutic Areas

Infectious Disease Respiratory Autoimmune

Curovir Pipeline

Drug	Indication	Phase
CUR-N399	Broad-spectrum Enterovirus Infections	Pre-clinical
Pleconaril	Type 1 Diabetes (exploratory)	Research

Leadership Team at Curovir

Nina Lindblom, PhD

Head of Clinical and Business Development

Jacob Westman, PhD, Assoc. Prof.

Head of Preclinical Research and Development

Gustav Arbrandt, MSc

View full Curovir profile